Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Neriman Gokden

Concepts (363)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
13
2021
181
2.370
Why?
Carcinoma, Renal Cell
13
2021
112
2.060
Why?
Kidney Diseases
8
2020
230
1.050
Why?
Kidney
16
2025
717
1.030
Why?
Immunohistochemistry
14
2021
975
1.030
Why?
PAX2 Transcription Factor
4
2010
24
0.960
Why?
Kidney Tubules
7
2021
63
0.930
Why?
Acute Kidney Injury
10
2026
400
0.890
Why?
Immunoglobulin Light Chains
4
2017
90
0.720
Why?
Neoplasms, Complex and Mixed
1
2020
2
0.650
Why?
Rhabdoid Tumor
1
2020
13
0.640
Why?
Stromal Cells
1
2020
77
0.620
Why?
Soft Tissue Neoplasms
1
2020
62
0.600
Why?
Immune Complex Diseases
2
2008
6
0.530
Why?
Sepsis
7
2014
240
0.490
Why?
Mitogen-Activated Protein Kinases
2
2008
152
0.460
Why?
Reperfusion Injury
2
2026
83
0.440
Why?
Adenoma
2
2021
114
0.400
Why?
Adenoma, Oxyphilic
2
2010
11
0.390
Why?
Male
39
2025
27444
0.380
Why?
Carcinoma, Papillary
2
2010
50
0.380
Why?
Renal Circulation
5
2013
57
0.350
Why?
Prostatic Neoplasms
5
2010
401
0.350
Why?
Middle Aged
26
2025
13422
0.350
Why?
Humans
44
2025
53246
0.330
Why?
Proteinuria
2
2010
38
0.330
Why?
Glomerulonephritis, IGA
1
2010
6
0.330
Why?
Podocytes
1
2010
22
0.320
Why?
Microcirculation
5
2014
63
0.320
Why?
Nephrectomy
2
2010
81
0.310
Why?
Antigens, Neoplasm
2
2008
146
0.310
Why?
Microscopy, Electron, Transmission
5
2014
68
0.310
Why?
Neurofibromatosis 2
1
2009
8
0.300
Why?
DNA Glycosylases
1
2008
19
0.280
Why?
Female
26
2025
28792
0.270
Why?
Adult
19
2023
14541
0.270
Why?
Renal Insufficiency
4
2013
108
0.270
Why?
Lymph Nodes
1
2010
252
0.270
Why?
Plasmacytoma
2
2020
45
0.270
Why?
Kidney Glomerulus
1
2008
43
0.270
Why?
Diagnosis, Differential
6
2021
1038
0.250
Why?
Hypercalcemia
1
2007
34
0.250
Why?
DNA Repair
1
2008
197
0.250
Why?
Alphapapillomavirus
1
2006
14
0.250
Why?
Sensitivity and Specificity
5
2011
869
0.250
Why?
Predictive Value of Tests
6
2025
933
0.250
Why?
Carcinoma
2
2020
136
0.240
Why?
Bone Density Conservation Agents
1
2007
75
0.240
Why?
Receptor, Anaphylatoxin C5a
1
2026
6
0.240
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2006
62
0.240
Why?
Imidazoles
1
2007
114
0.240
Why?
Diphosphonates
1
2007
92
0.240
Why?
Hepatitis B
1
2006
15
0.240
Why?
DNA, Viral
1
2006
136
0.240
Why?
Urinary Bladder Neoplasms
3
2014
167
0.240
Why?
Glomerulosclerosis, Focal Segmental
1
2006
20
0.240
Why?
Prostatic Intraepithelial Neoplasia
2
2005
8
0.230
Why?
Complement C5
1
2025
5
0.230
Why?
Biopsy
6
2020
600
0.230
Why?
Skin Neoplasms
2
2018
500
0.230
Why?
Adenocarcinoma
2
2010
405
0.230
Why?
Cisplatin
4
2025
282
0.220
Why?
Insulin-Like Growth Factor Binding Protein 1
1
2025
16
0.220
Why?
Neoplasms, Multiple Primary
1
2005
44
0.210
Why?
Aged
14
2025
10430
0.210
Why?
Metformin
1
2025
84
0.200
Why?
Paraproteinemias
2
2016
72
0.200
Why?
Pheochromocytoma
1
2023
34
0.200
Why?
Adrenal Gland Neoplasms
1
2023
49
0.200
Why?
Aged, 80 and over
8
2017
3495
0.200
Why?
Hypoglycemic Agents
1
2025
227
0.190
Why?
Animals
18
2026
13528
0.190
Why?
Dermatofibrosarcoma
1
2003
9
0.190
Why?
Proteasome Endopeptidase Complex
1
2024
142
0.190
Why?
Oncogene Proteins, Fusion
1
2003
62
0.190
Why?
Mitochondria
1
2026
447
0.180
Why?
Renal Insufficiency, Chronic
1
2025
205
0.180
Why?
Kidney Transplantation
1
2024
204
0.170
Why?
Kidney Diseases, Cystic
1
2021
18
0.170
Why?
Multiple Myeloma
3
2017
3082
0.170
Why?
Immunoglobulin G
2
2014
192
0.170
Why?
Disease Models, Animal
6
2025
1517
0.160
Why?
Rats
5
2026
3164
0.160
Why?
Precancerous Conditions
1
2021
87
0.160
Why?
Carcinoma, Transitional Cell
2
2012
54
0.160
Why?
Qb-SNARE Proteins
1
2019
6
0.150
Why?
Qc-SNARE Proteins
1
2019
10
0.150
Why?
Neoplasms, Plasma Cell
1
2020
35
0.150
Why?
Actin Cytoskeleton
1
2019
22
0.150
Why?
Antineoplastic Agents
3
2017
1232
0.150
Why?
Hepatic Stellate Cells
1
2019
18
0.150
Why?
Myofibroblasts
1
2019
50
0.150
Why?
Retrospective Studies
6
2025
6821
0.150
Why?
Neoplasm Metastasis
2
2010
237
0.140
Why?
Cell Nucleus
2
2010
187
0.140
Why?
Kidney Failure, Chronic
1
2021
210
0.140
Why?
Mice
12
2025
5982
0.140
Why?
Myoblasts
1
2018
19
0.130
Why?
Melanoma
2
2018
277
0.130
Why?
Synovitis
1
2017
21
0.130
Why?
Capillaries
4
2014
53
0.130
Why?
Cell Proliferation
1
2021
1031
0.130
Why?
Eosinophilia
1
2017
34
0.130
Why?
DNA, Neoplasm
3
2008
146
0.120
Why?
Obesity
1
2025
1205
0.120
Why?
Angiomyolipoma
1
2016
9
0.120
Why?
Thoracic Neoplasms
1
2016
12
0.120
Why?
Tuberous Sclerosis
1
2016
38
0.120
Why?
Tumor Suppressor Proteins
1
2016
130
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2017
238
0.110
Why?
Receptors, Lysosphingolipid
1
2014
7
0.110
Why?
Reactive Nitrogen Species
3
2011
23
0.110
Why?
Urothelium
1
2014
20
0.110
Why?
Hemangiosarcoma
1
2014
18
0.110
Why?
Mice, Inbred C57BL
6
2025
1925
0.110
Why?
Neoplasm Staging
3
2014
774
0.100
Why?
Oxidative Stress
2
2025
820
0.100
Why?
Immunoglobulin kappa-Chains
1
2014
22
0.100
Why?
Necrosis
2
2012
169
0.100
Why?
Glomerulonephritis, Membranous
1
2014
28
0.100
Why?
Rolipram
1
2013
3
0.100
Why?
Phosphodiesterase 4 Inhibitors
1
2013
5
0.100
Why?
Microscopy, Electron
2
2020
63
0.100
Why?
Molecular Targeted Therapy
1
2014
138
0.100
Why?
Glomerular Filtration Rate
4
2017
128
0.100
Why?
Translocation, Genetic
2
2005
266
0.100
Why?
Prospective Studies
2
2010
2412
0.090
Why?
Sarcoidosis
1
2013
44
0.090
Why?
Organ Preservation
2
2024
34
0.090
Why?
Livedo Reticularis
1
2012
5
0.090
Why?
Cryoglobulinemia
1
2012
13
0.090
Why?
Lipoprotein Lipase
1
2012
14
0.090
Why?
DNA, Mitochondrial
2
2003
116
0.090
Why?
Metalloporphyrins
1
2011
6
0.090
Why?
Free Radical Scavengers
1
2011
24
0.090
Why?
Cellular Microenvironment
1
2011
30
0.090
Why?
Microscopy, Fluorescence
2
2014
140
0.090
Why?
Polymerase Chain Reaction
3
2008
452
0.090
Why?
Adrenal Cortex Neoplasms
1
2011
5
0.090
Why?
Myocardium
2
2017
471
0.080
Why?
Triglycerides
1
2012
171
0.080
Why?
Stilbenes
1
2011
58
0.080
Why?
Tissue Array Analysis
2
2011
45
0.080
Why?
Peritoneal Neoplasms
1
2012
68
0.080
Why?
Metalloendopeptidases
1
2011
70
0.080
Why?
Hematuria
1
2010
25
0.080
Why?
Fluorescent Antibody Technique
1
2010
109
0.080
Why?
Ejaculatory Ducts
1
2010
3
0.080
Why?
Seminal Vesicles
1
2010
13
0.080
Why?
Plasma Cells
1
2012
234
0.080
Why?
Hemodynamics
1
2011
236
0.080
Why?
RNA, Messenger
4
2012
1133
0.080
Why?
In Situ Hybridization
2
2006
69
0.080
Why?
Antioxidants
1
2011
264
0.070
Why?
Prostate
1
2010
118
0.070
Why?
Epithelial Cells
2
2011
218
0.070
Why?
Lymphatic Metastasis
1
2010
211
0.070
Why?
Fatal Outcome
1
2009
193
0.070
Why?
Survival Analysis
3
2017
659
0.070
Why?
Iron Chelating Agents
1
2008
12
0.070
Why?
Ligation
3
2014
63
0.070
Why?
Nephritis, Interstitial
1
2008
9
0.070
Why?
Benzoates
1
2008
22
0.070
Why?
Microsatellite Repeats
1
2008
41
0.070
Why?
Loss of Heterozygosity
1
2008
78
0.070
Why?
Glomerular Mesangium
1
2008
6
0.070
Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.070
Why?
Basement Membrane
1
2008
19
0.070
Why?
Triazoles
1
2008
114
0.070
Why?
Cell Membrane
1
2008
233
0.070
Why?
Disease Progression
2
2025
880
0.060
Why?
Glomerular Basement Membrane
1
2007
10
0.060
Why?
Mutation
2
2003
1338
0.060
Why?
Kidney Pelvis
1
2006
16
0.060
Why?
Prednisone
1
2007
101
0.060
Why?
Paraffin Embedding
1
2006
52
0.060
Why?
Tumor Necrosis Factor-alpha
2
2025
392
0.060
Why?
Rats, Sprague-Dawley
2
2025
1544
0.060
Why?
Karyotyping
3
2017
77
0.060
Why?
Prognosis
2
2025
2118
0.060
Why?
Signal Transduction
2
2026
1748
0.060
Why?
Heart Diseases
1
2009
221
0.060
Why?
Young Adult
4
2021
4514
0.060
Why?
Nephrotic Syndrome
1
2006
35
0.060
Why?
Gene Knockout Techniques
1
2025
50
0.060
Why?
Mice, Knockout
2
2025
910
0.060
Why?
Clofibric Acid
1
2005
7
0.060
Why?
Chemokine CCL2
1
2025
66
0.060
Why?
Chromosomes, Human, Pair 2
1
2005
25
0.060
Why?
Chromosomes, Human, Pair 7
1
2005
29
0.060
Why?
Rats, Zucker
1
2025
73
0.060
Why?
Lipopolysaccharides
1
2006
203
0.060
Why?
Chromosomes, Human, Pair 5
1
2005
17
0.050
Why?
Glucocorticoids
1
2007
236
0.050
Why?
Chromosomes, Human, Pair 9
1
2005
20
0.050
Why?
Neurofibroma
1
2005
18
0.050
Why?
Blood Pressure
3
2011
518
0.050
Why?
Fibroma
1
2005
41
0.050
Why?
Foot
1
2005
41
0.050
Why?
Anti-Bacterial Agents
1
2011
832
0.050
Why?
Protein Synthesis Inhibitors
1
2004
14
0.050
Why?
Biopsy, Needle
1
2005
181
0.050
Why?
Endodeoxyribonucleases
1
2004
47
0.050
Why?
Administration, Oral
1
2025
456
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2005
124
0.050
Why?
Adrenalectomy
1
2023
31
0.050
Why?
Adrenal Glands
1
2023
38
0.050
Why?
Gene Expression Regulation, Enzymologic
1
2004
180
0.050
Why?
Groin
1
2003
16
0.050
Why?
Vulva
1
2003
18
0.050
Why?
Time Factors
3
2014
2992
0.050
Why?
RNA, Neoplasm
1
2003
45
0.050
Why?
Proteasome Inhibitors
1
2024
104
0.050
Why?
Micromanipulation
1
2002
2
0.050
Why?
Cytoplasm
1
2003
93
0.050
Why?
Immunoenzyme Techniques
1
2003
134
0.050
Why?
Biopsy, Fine-Needle
1
2003
104
0.050
Why?
Blotting, Western
3
2012
587
0.050
Why?
Perfusion
1
2002
49
0.050
Why?
Sodium Chloride
1
2002
53
0.050
Why?
Neoplasm Invasiveness
2
2014
281
0.050
Why?
Blood Flow Velocity
2
2013
99
0.050
Why?
Sequence Analysis, DNA
1
2003
216
0.040
Why?
Hypothermia, Induced
1
2002
46
0.040
Why?
Mass Screening
1
2005
362
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
579
0.040
Why?
Cardiac Surgical Procedures
1
2025
331
0.040
Why?
Severity of Illness Index
1
2025
1049
0.040
Why?
Capillary Permeability
2
2011
29
0.040
Why?
Bone Neoplasms
1
2003
188
0.040
Why?
Adolescent
3
2014
6912
0.040
Why?
Transcription Factors
1
2004
571
0.040
Why?
Hyperplasia
1
2021
98
0.040
Why?
Inflammation
1
2025
653
0.040
Why?
Liver
2
2019
1150
0.040
Why?
Cell Differentiation
2
2014
681
0.040
Why?
Apoptosis
1
2025
1139
0.040
Why?
Clinical Laboratory Techniques
1
2020
28
0.040
Why?
In Situ Hybridization, Fluorescence
1
2021
266
0.040
Why?
Heart Rate
2
2011
313
0.040
Why?
Stress Fibers
1
2019
5
0.040
Why?
Actin Depolymerizing Factors
1
2019
5
0.040
Why?
Treatment Outcome
3
2017
5597
0.040
Why?
rho-Associated Kinases
1
2019
21
0.040
Why?
Carbon Tetrachloride
1
2019
25
0.040
Why?
RNA, Viral
1
2020
123
0.040
Why?
Cell Separation
1
2019
76
0.040
Why?
Gene Knockdown Techniques
1
2019
109
0.040
Why?
Nitrites
2
2011
31
0.040
Why?
Child, Preschool
2
2011
4164
0.040
Why?
Liver Neoplasms
1
2003
347
0.040
Why?
Nitrates
2
2011
30
0.040
Why?
Antibodies, Monoclonal
1
2003
477
0.040
Why?
RNA Interference
1
2019
181
0.040
Why?
Actins
1
2019
114
0.040
Why?
RNA, Small Interfering
1
2019
214
0.040
Why?
Neutrophil Infiltration
2
2012
25
0.040
Why?
Cecum
2
2011
62
0.040
Why?
Cell Movement
1
2019
279
0.030
Why?
Cell Dedifferentiation
1
2018
8
0.030
Why?
Wound Healing
1
2019
226
0.030
Why?
Reactive Oxygen Species
2
2011
421
0.030
Why?
Kidney Function Tests
1
2017
55
0.030
Why?
Liver Cirrhosis
1
2019
246
0.030
Why?
Microscopy, Video
2
2007
8
0.030
Why?
Lung Neoplasms
1
2003
645
0.030
Why?
Cell Line
1
2019
1016
0.030
Why?
Nitric Oxide Synthase Type II
2
2007
64
0.030
Why?
Acute Disease
2
2008
393
0.030
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.030
Why?
Risk Factors
1
2005
4018
0.030
Why?
Genomics
1
2017
271
0.030
Why?
Cysts
1
2016
53
0.030
Why?
Bone Marrow
1
2017
359
0.030
Why?
Immunotherapy
1
2017
266
0.030
Why?
Oxadiazoles
1
2014
9
0.030
Why?
Punctures
1
2014
52
0.030
Why?
Permeability
1
2014
70
0.030
Why?
Thiophenes
1
2014
45
0.030
Why?
Antigen-Antibody Complex
1
2014
35
0.030
Why?
Terminology as Topic
1
2014
72
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2014
73
0.020
Why?
Pyrazoles
1
2014
123
0.020
Why?
Pyridines
1
2014
135
0.020
Why?
Granuloma
1
2013
46
0.020
Why?
Bone Marrow Examination
1
2012
11
0.020
Why?
Receptors, Lipoprotein
1
2012
7
0.020
Why?
Azo Compounds
1
2012
11
0.020
Why?
Angiopoietins
1
2012
6
0.020
Why?
Peroxisome Proliferator-Activated Receptors
1
2012
16
0.020
Why?
Plasma Exchange
1
2012
25
0.020
Why?
Coloring Agents
1
2012
65
0.020
Why?
Adipose Tissue, White
1
2012
35
0.020
Why?
Immunosuppressive Agents
1
2014
253
0.020
Why?
Epithelium
1
2011
64
0.020
Why?
Cystectomy
1
2012
52
0.020
Why?
Cell Hypoxia
1
2011
82
0.020
Why?
Child
2
2016
7384
0.020
Why?
Dose-Response Relationship, Drug
1
2014
1367
0.020
Why?
Superoxide Dismutase
1
2011
122
0.020
Why?
Telemetry
1
2011
27
0.020
Why?
Peritonitis
1
2011
24
0.020
Why?
Vasodilator Agents
1
2011
90
0.020
Why?
Multiple Organ Failure
1
2011
51
0.020
Why?
Hydroxamic Acids
1
2011
38
0.020
Why?
Hypothermia
1
2011
38
0.020
Why?
Fluid Therapy
1
2011
79
0.020
Why?
Oxidation-Reduction
1
2011
333
0.020
Why?
Interleukin-1beta
1
2011
88
0.020
Why?
United States
1
2021
5413
0.020
Why?
Body Weight
1
2012
524
0.020
Why?
Animals, Newborn
1
2011
357
0.020
Why?
Membrane Proteins
1
2012
333
0.020
Why?
Gene Expression
1
2012
618
0.020
Why?
Skin
1
2012
420
0.020
Why?
Infant, Newborn
1
2016
2913
0.020
Why?
Cells, Cultured
1
2012
1569
0.020
Why?
Iron Overload
1
2008
9
0.020
Why?
Eosinophils
1
2008
40
0.020
Why?
Erythrocyte Transfusion
1
2008
53
0.020
Why?
Drug Hypersensitivity
1
2008
46
0.020
Why?
Myelodysplastic Syndromes
1
2008
87
0.020
Why?
NADP
1
2006
23
0.020
Why?
Blood Urea Nitrogen
1
2006
40
0.020
Why?
Lysine
1
2007
91
0.020
Why?
Creatinine
1
2006
158
0.010
Why?
Nitric Oxide
1
2007
233
0.010
Why?
Nuclease Protection Assays
1
2005
2
0.010
Why?
Receptors, CCR1
1
2005
10
0.010
Why?
Receptors, CCR5
1
2005
7
0.010
Why?
Receptors, Chemokine
1
2005
12
0.010
Why?
Stress, Physiological
1
2006
184
0.010
Why?
Chemokine CCL5
1
2005
9
0.010
Why?
Electrophoretic Mobility Shift Assay
1
2005
71
0.010
Why?
Intercellular Adhesion Molecule-1
1
2005
59
0.010
Why?
Vascular Cell Adhesion Molecule-1
1
2005
38
0.010
Why?
Enzyme Inhibitors
1
2007
371
0.010
Why?
Chemokines
1
2005
78
0.010
Why?
Muscle Neoplasms
1
2005
17
0.010
Why?
PPAR alpha
1
2005
61
0.010
Why?
Prostatectomy
1
2005
84
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2005
233
0.010
Why?
Chromosome Mapping
1
2005
145
0.010
Why?
Kidney Tubules, Proximal
1
2004
60
0.010
Why?
Receptors, Cytoplasmic and Nuclear
1
2004
65
0.010
Why?
Ligands
1
2004
203
0.010
Why?
Cell Death
1
2004
171
0.010
Why?
Pyrimidines
1
2005
206
0.010
Why?
Antigens, CD
1
2005
217
0.010
Why?
NF-kappa B
1
2005
327
0.010
Why?
Models, Genetic
1
2003
169
0.010
Why?
Multigene Family
1
2002
50
0.010
Why?
Lasers
1
2002
64
0.010
Why?
Infant
1
2011
3808
0.010
Why?
Renal Artery Obstruction
1
2002
20
0.010
Why?
Base Sequence
1
2003
620
0.010
Why?
Cytokines
1
2005
627
0.010
Why?
Polymorphism, Genetic
1
2002
181
0.010
Why?
Models, Animal
1
2002
233
0.010
Why?
Ischemia
1
2002
158
0.010
Why?
Swine
1
2002
440
0.010
Why?
Feasibility Studies
1
2002
412
0.010
Why?
Laparoscopy
1
2002
180
0.010
Why?
Gokden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description